Status:
UNKNOWN
Combined Treatment of Platelet-rich Plasma (PRP) and Low-intensity Extracorporeal Shockwave Therapy (Li-ESWT) on Erectile Dysfunction (ED)
Lead Sponsor:
Taipei Medical University Hospital
Conditions:
Erectile Dysfunction
Eligibility:
MALE
30-80 years
Phase:
NA
Brief Summary
The purpose of this clinical study is mainly to use platelet-rich plasma combined with low-intensity extracorporeal shockwave therapy to treat patients with erectile dysfunction and observe the improv...
Detailed Description
According to statistics from the Taiwan Society of Andrology, 18 to 25 years old male population in Taiwan having erectile dysfunction (ED) trouble is as high as 5 to 10 percent. At the same time, sta...
Eligibility Criteria
Inclusion
- Impotence for more than three months
- International index of erectile function, (IIEF) less than 21( including 21)
- Erectile hardness score, (EHS) less than 3( including 3)
- Age over 30 years old
Exclusion
- Hypogonadism
- Bleeding tendency
- Could not cooperate with the treatment
- AIDS, syphilis and condyloma victim
- Received radical prostatectomy
- Prostate cancer or pelvis malignant tumor victim
- Gonad dysfunction
- Penis deformities
- Penile prosthesis implantation
- Psychiatric disease victim
- Neural disease ( multiple myeloma , brain atrophy, etc)
- Pacemaker implantation
- Not suitable join this trial judged by Investigator
- Alcohol or drug abuse
Key Trial Info
Start Date :
December 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04416802
Start Date
December 28 2020
End Date
October 1 2024
Last Update
October 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University Hospital
Taipei, Taiwan, 110